Home › News and Press › Page 3

News and Press releases

View all News Press releases

Sandra Ekstedt presents OXC-201 at the ERS 10th of September

September 4, 2023 · News and Press

Christina Kalderén presents at the IPF Summit September 19-21st

August 31, 2023 · News and Press

Oxcia AB (publ) publishes interim report for the second quarter 2023

August 25, 2023 · News and Press

OXC-101 as a novel therapy for AML will be presented at 18[th] Annual Congress of International Drug Discovert Science & Technology, Amsterdam 12-14 July, 2023

August 23, 2023 · News and Press

OXC-101 as a novel therapy for AML will be presented at 18[th] Annual Congress of International Drug Discovery Science & Technology, Amsterdam 12-14 July, 2023

June 30, 2023 · News and Press

Oxcia AB (publ) publishes annual report

May 16, 2023 · News and Press

Oxcia AB (publ) publishes interim report fort the first quarter 2023

April 26, 2023 · News and Press

Oxcia has been awarded a grant of 3 million SEK for a study in refractory AML patients

April 3, 2023 · News and Press

Three abstracts on OXC-101 selected for poster presentations at AACR 2023

March 30, 2023 · News and Press

New pre-clinical study shows that OXC-201 may be a promising treatment for IPF (pulmonary fibrosis)

March 2, 2023 · News and Press

The EIC has awarded Oxcia AB with a EIC transition grant of 2.5 million Euros for development of OXC-201.

February 24, 2023 · News and Press

Oxcia AB publishes Year-End Report for 2022

February 15, 2023 · News and Press

Search